Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy

被引：4

作者：

Deng, Xiyun ^{[1
]}

Zheng, Chanjuan ^{[1
]}

Tang, Faqing ^{[2
,3
]}

Rosol, Thomas J. J. ^{[4
]}

Shao, Zhi-Ming ^{[5
,6
]}

机构：

[1] Hunan Normal Univ, Key Lab Translat Canc Stem Cell Res, Sch Med, Changsha, Hunan, Peoples R China

[2] Cent South Univ, Xiangya Sch Med, Hunan Key Lab Oncotarget Gene, Clin Lab,Hunan Canc Hosp, Changsha, Hunan, Peoples R China

[3] Cent South Univ, Affiliated Canc Hosp, Hunan Key Lab Oncotarget Gene, Xiangya Sch Med, Changsha, Hunan, Peoples R China

[4] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH USA

[5] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai,Dept Breast Surg, Shanghai, Peoples R China

[6] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2022年 / 12卷

基金：

中国国家自然科学基金;

关键词：

triple-negative breast cancer; heterogeneity; tumor microenvironment; targeted therapy; clinical outcomes;

D O I：

10.3389/fonc.2022.1026566

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 18 条

[11] Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer [J].

Parsons, Heather A. ;

Beaver, Julia A. ;

Cimino-Mathews, Ashley ;

Ali, Siraj M. ;

Axilbund, Jennifer ;

Chu, David ;

Connolly, Roisin M. ;

Cochran, Rory L. ;

Croessmann, Sarah ;

Clark, Travis A. ;

Gocke, Christopher D. ;

Jeter, Stacie C. ;

Kennedy, Mark R. ;

Lauring, Josh ;

Lee, Justin ;

Lipson, Doron ;

Miller, Vincent A. ;

Otto, Geoff A. ;

Rosner, Gary L. ;

Ross, Jeffrey S. ;

Slater, Shannon ;

Stephens, Philip J. ;

VanDenBerg, Dustin A. ;

Wolff, Antonio C. ;

Young, Lauren E. ;

Zabransky, Daniel J. ;

Zhang, Zhe ;

Zorzi, Jane ;

Stearns, Vered ;

Park, Ben H. .

CLINICAL CANCER RESEARCH, 2017, 23 (02) :379-386

[12] Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer [J].

Savas, Peter ;

Loi, Sherene .

CANCER CELL, 2020, 37 (05) :623-624

[13] Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation [J].

Shi, Peiguo ;

Liu, Wenjing ;

Tala ;

Wang, Haixia ;

Li, Fubing ;

Zhang, Hailin ;

Wu, Yingying ;

Kong, Yanjie ;

Zhou, Zhongmei ;

Wang, Chunyan ;

Chen, Wenlin ;

Liu, Rong ;

Chen, Ceshi .

CELL DISCOVERY, 2017, 3

[14] TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy [J].

Singh, Desh Deepak ;

Yadav, Dharmendra Kumar .

BIOMEDICINES, 2021, 9 (08)

[15] Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier [J].

Vafaei, Somayeh ;

Zekiy, Angelina O. ;

Khanamir, Ramadhan Ado ;

Zaman, Burhan Abdullah ;

Ghayourvahdat, Arman ;

Azimizonuzi, Hannaneh ;

Zamani, Majid .

CANCER CELL INTERNATIONAL, 2022, 22 (01)

[16] Salinomycin Derivatives Kill Breast Cancer Stem Cells by Lysosomal Iron Targeting [J].

Versini, Antoine ;

Colombeau, Ludovic ;

Hienzsch, Antje ;

Gaillet, Christine ;

Retailleau, Pascal ;

Debieu, Sylvain ;

Muller, Sebastian ;

Caneque, Tatiana ;

Rodriguez, Raphael .

CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (33) :7416-7424

[17] Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end? [J].

Wojtukiewicz, Marek Z. ;

Pogorzelska, Magda ;

Politynska, Barbara .

CANCER AND METASTASIS REVIEWS, 2022, 41 (03) :465-469

[18] A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer [J].

Xie, Jindong ;

Zou, Yutian ;

Ye, Feng ;

Zhao, Wanzhen ;

Xie, Xinhua ;

Ou, Xueqi ;

Xie, Xiaoming ;

Wei, Weidong .

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9

← 1 2 →